Yow-Pin Lim, Ph.D., M.D. – Research Oncologist, Department of Medicine/Div. Hematology-Oncology, Rhode Island Hospital; Assistant Professor, Brown University School of Medicine; and Co-founder, Prothera Biologics

Yow-Pin is the co-founder and Chief Scientific Officer of ProThera Biologics, a start-up company in East Providence, RI. He is currently Assistant Professor at Brown Medical School and Research Oncologist in the Department of Medicine/Div. Hematology-Oncology, Rhode Island Hospital. ProThera was formed as a spin-off from technology developed at Rhode Island Hospital with the mission to develop and commercialize protein-based “theranostic” and therapeutic products for various human diseases. Theranostics refers to a new market area with enormous potential for growth which utilizes predictive tests to make critical and personalized treatment decisions. Yow-Pin graduated from the Medical School (Free University Berlin) in Germany and earned MD-Ph.D. degree in 1991. His research focuses on the role of natural serine protease inhibitors in systemic inflammation/sepsis and cancer metastasis. He has generated unique monoclonal antibodies against Inter-alpha Inhibitors (IaI) and has made major contributions to the understanding of these complex molecules in human physiology and in human disease states. He has established an accurate and sensitive immunoassay for IaI in biological fluids and is actively conducting translational studies focusing on the clinical application of IaI as a novel marker and therapeutic agent in sepsis and cancer.